Luo L, Yuan W, Tian J, Zhang Y
Cancer Institute, CAMS, Beijing.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1996 Dec;18(6):416-22.
Malignant tumor growth is always accompanied with immune suppression. Tumor-derived immuno-suppressive factors, among others, are thought to be responsible, but their nature is not well defined. The paper reports on the expression of an immuno-suppressive retroviral transmembrane envelope protein p15E at different levels in human cancer cells. By using immunohistochemistry, enzyme-linked immunosorbent assay, flow cytometry and in situ hybridization, p15E expression could be demonstrated in cancers of the esophagus, nosopharynx, rectum, ovary (including malignant effusion and cell lines), stomach and breast. Enhanced expression of p15E was also observed in activated lymphocytes of cancer patients as shown by RT-PCR technique. The results indicate that p15E of tumor origin, and perhaps that from activated lymphocytes, may contribute to the immune suppression associated with malignancy.
恶性肿瘤的生长总是伴随着免疫抑制。人们认为肿瘤衍生的免疫抑制因子等对此负有责任,但其性质尚未明确界定。该论文报道了一种免疫抑制逆转录病毒跨膜包膜蛋白p15E在人类癌细胞中的不同水平表达。通过免疫组织化学、酶联免疫吸附测定、流式细胞术和原位杂交,在食管癌、鼻咽癌、直肠癌、卵巢癌(包括恶性积液和细胞系)、胃癌和乳腺癌中均可检测到p15E的表达。逆转录聚合酶链反应技术显示,癌症患者活化淋巴细胞中也观察到p15E表达增强。结果表明,肿瘤来源的p15E,或许还有活化淋巴细胞来源的p15E,可能与恶性肿瘤相关的免疫抑制有关。